Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 24, No 9 (March 20), 2006: pp. 1480
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.04.8538

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorresteijn, L. D.
Right arrow Articles by Boogerd, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorresteijn, L. D.
Right arrow Articles by Boogerd, W.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

Stroke As a Late Treatment Effect of Hodgkin's Disease

Lucille Désirée Dorresteijn

Department of Neurology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Fiona Anne Stewart, Willem Boogerd

Division of Experimental Therapy and Department of Neuro-Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

To the Editor:

Bowers et al1 are commended for their large cohort study on the risk of stroke in long-term survivors of Hodgkin's disease. This is the first study showing an absolute increased risk of stroke in these young patients, who were not prone to atherosclerotic diseases because of their age. After a median interval of 17.5 years, these patients have an increased relative risk of stroke of 4.3 in comparison with a sibling control group. This observed increased risk is in agreement with the elevated risk of stroke we found in patients irradiated for head and neck tumors.2 However, the interval before the onset of stroke is longer in the Hodgkin's population: 17.5 years versus 10.9 years in the head and neck population. This could possibly be explained by differences in underlying pathogenetic mechanisms. In atherosclerotic-naive patients, like in the Hodgkin's population, irradiation on the neck seems to induce atherosclerotic-like lesions of the carotid artery. In contrast, in the population of older patients with head and neck cancer, radiation therapy (RT) accelerates pre-existing atherosclerotic disease. Both processes can eventually cause stenosis of the carotid artery3 and thromboembolisms leading to stroke, but the timing of this depends on whether the atherosclerotic process was already initiated before irradiation. In addition, increased thickness of the carotid vascular wall in the older head and neck cancer patients might sooner induce flow disturbances and shear stress, further accelerating the atherosclerotic process. The relatively low-dose of RT used in the treatment of Hodgkin's disease (median dose, 40 Gy) compared with the dose used for head and neck cancer (60 to 70 Gy) might also contribute to slower progression of the lesions.

A limitation of the Bowers study is that stroke was not confirmed by a computed tomography scan. Therefore, the contribution of other causes of cerebrovascular disease, like intracranial hemorrhage, cannot be established, nor can the origin of stroke be ascertained. Hodgkin's disease patients who receive mantle irradiation are also at risk for cardiac disease, such as valvular diseases,4 which can also result in stroke in these patients.

We agree with the authors that patients who receive irradiation on the neck should be monitored, especially those patients who have an estimated long survival. However, the suggestion of interviewing patients to establish the occurrence of cerebrovascular disease is, in our view, not the most appropriate solution, because the damage has already been done by then. We suggest duplex screening of the carotid arteries as a crucial part of follow-up to identify damage before it is associated with clinical symptoms. The next step is to investigate possible intervention strategies in order to diminish these debilitating late complications in long-term survivors of cancer.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Bowers DC, McNeil DE, Liu Y, et al: Stroke as a late treatment effect of Hodgkin's Disease: A report from the Childhood Cancer Survivor Study. J Clin Oncol 23:6508-6515, 2005[Abstract/Free Full Text]

2. Dorresteijn LD, Kappelle AC, Boogerd W, et al: Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 20:282-288, 2002[Abstract/Free Full Text]

3. Cheng SW, Ting AC, Lam LK, et al: Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 126:517-521, 2000[Abstract/Free Full Text]

4. Hull MC, Morris CG, Pepine CJ, et al: Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 290:2831-2837, 2003[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Reply

  • In Reply:
    Daniel C. Bowers and Kevin C. Oeffinger
    JCO 2006 24: 1480-1481 [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorresteijn, L. D.
Right arrow Articles by Boogerd, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorresteijn, L. D.
Right arrow Articles by Boogerd, W.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online